Condition

Conjunctivitis (2)

Allergic Rhinitis (1)

Atopic Dermatitis (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Regeneron Pharmaceuticals (2)

Collaborator

Sanofi (1)

Intervention

dupilumab (1)

placebo (1)

regn5713 (1)

regn5714 (1)

regn5715 (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (1)

Observational (1)

Conjunctivitis

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Conjunctivitis in Setting of DUPIXENT® Treatment for Atopic

Active, not recruiting

Conjunctivitis
Atopic Dermatitis

dupilumab

Irvine, California
+14 more

Jul 8, 2022

Allergic Rhinitis, Conjunctivitis Trial in Worldwide (REGN5713, REGN5714, REGN5715)

Completed

Allergic Rhinitis
Conjunctivitis

REGN5713
+3 more

Bangor, Maine
+36 more

Nov 5, 2021